Long noncoding intronic RNAs are differentially expressed in primary and metastatic pancreatic cancer

<p>Abstract</p> <p>Background</p> <p>Pancreatic ductal adenocarcinoma (PDAC) is known by its aggressiveness and lack of effective therapeutic options. Thus, improvement in current knowledge of molecular changes associated with pancreatic cancer is urgently needed to exp...

Full description

Bibliographic Details
Main Authors: Tahira Ana C, Kubrusly Márcia S, Faria Michele F, Dazzani Bianca, Fonseca Rogério S, Maracaja-Coutinho Vinicius, Verjovski-Almeida Sergio, Machado Marcel CC, Reis Eduardo M
Format: Article
Language:English
Published: BMC 2011-11-01
Series:Molecular Cancer
Subjects:
Online Access:http://www.molecular-cancer.com/content/10/1/141
_version_ 1818065595744124928
author Tahira Ana C
Kubrusly Márcia S
Faria Michele F
Dazzani Bianca
Fonseca Rogério S
Maracaja-Coutinho Vinicius
Verjovski-Almeida Sergio
Machado Marcel CC
Reis Eduardo M
author_facet Tahira Ana C
Kubrusly Márcia S
Faria Michele F
Dazzani Bianca
Fonseca Rogério S
Maracaja-Coutinho Vinicius
Verjovski-Almeida Sergio
Machado Marcel CC
Reis Eduardo M
author_sort Tahira Ana C
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>Pancreatic ductal adenocarcinoma (PDAC) is known by its aggressiveness and lack of effective therapeutic options. Thus, improvement in current knowledge of molecular changes associated with pancreatic cancer is urgently needed to explore novel venues of diagnostics and treatment of this dismal disease. While there is mounting evidence that long noncoding RNAs (lncRNAs) transcribed from intronic and intergenic regions of the human genome may play different roles in the regulation of gene expression in normal and cancer cells, their expression pattern and biological relevance in pancreatic cancer is currently unknown. In the present work we investigated the relative abundance of a collection of lncRNAs in patients' pancreatic tissue samples aiming at identifying gene expression profiles correlated to pancreatic cancer and metastasis.</p> <p>Methods</p> <p>Custom 3,355-element spotted cDNA microarray interrogating protein-coding genes and putative lncRNA were used to obtain expression profiles from 38 clinical samples of tumor and non-tumor pancreatic tissues. Bioinformatics analyses were performed to characterize structure and conservation of lncRNAs expressed in pancreatic tissues, as well as to identify expression signatures correlated to tissue histology. Strand-specific reverse transcription followed by PCR and qRT-PCR were employed to determine strandedness of lncRNAs and to validate microarray results, respectively.</p> <p>Results</p> <p>We show that subsets of intronic/intergenic lncRNAs are expressed across tumor and non-tumor pancreatic tissue samples. Enrichment of promoter-associated chromatin marks and over-representation of conserved DNA elements and stable secondary structure predictions suggest that these transcripts are generated from independent transcriptional units and that at least a fraction is under evolutionary selection, and thus potentially functional.</p> <p>Statistically significant expression signatures comprising protein-coding mRNAs and lncRNAs that correlate to PDAC or to pancreatic cancer metastasis were identified. Interestingly, <it>loci </it>harboring intronic lncRNAs differentially expressed in PDAC metastases were enriched in genes associated to the MAPK pathway. Orientation-specific RT-PCR documented that intronic transcripts are expressed in sense, antisense or both orientations relative to protein-coding mRNAs. Differential expression of a subset of intronic lncRNAs (<it>PPP3CB</it>, <it>MAP3K14 </it>and <it>DAPK1 loci</it>) in metastatic samples was confirmed by Real-Time PCR.</p> <p>Conclusion</p> <p>Our findings reveal sets of intronic lncRNAs expressed in pancreatic tissues whose abundance is correlated to PDAC or metastasis, thus pointing to the potential relevance of this class of transcripts in biological processes related to malignant transformation and metastasis in pancreatic cancer.</p>
first_indexed 2024-12-10T14:54:24Z
format Article
id doaj.art-4a71d27b5af649cc96145ace6828723b
institution Directory Open Access Journal
issn 1476-4598
language English
last_indexed 2024-12-10T14:54:24Z
publishDate 2011-11-01
publisher BMC
record_format Article
series Molecular Cancer
spelling doaj.art-4a71d27b5af649cc96145ace6828723b2022-12-22T01:44:20ZengBMCMolecular Cancer1476-45982011-11-0110114110.1186/1476-4598-10-141Long noncoding intronic RNAs are differentially expressed in primary and metastatic pancreatic cancerTahira Ana CKubrusly Márcia SFaria Michele FDazzani BiancaFonseca Rogério SMaracaja-Coutinho ViniciusVerjovski-Almeida SergioMachado Marcel CCReis Eduardo M<p>Abstract</p> <p>Background</p> <p>Pancreatic ductal adenocarcinoma (PDAC) is known by its aggressiveness and lack of effective therapeutic options. Thus, improvement in current knowledge of molecular changes associated with pancreatic cancer is urgently needed to explore novel venues of diagnostics and treatment of this dismal disease. While there is mounting evidence that long noncoding RNAs (lncRNAs) transcribed from intronic and intergenic regions of the human genome may play different roles in the regulation of gene expression in normal and cancer cells, their expression pattern and biological relevance in pancreatic cancer is currently unknown. In the present work we investigated the relative abundance of a collection of lncRNAs in patients' pancreatic tissue samples aiming at identifying gene expression profiles correlated to pancreatic cancer and metastasis.</p> <p>Methods</p> <p>Custom 3,355-element spotted cDNA microarray interrogating protein-coding genes and putative lncRNA were used to obtain expression profiles from 38 clinical samples of tumor and non-tumor pancreatic tissues. Bioinformatics analyses were performed to characterize structure and conservation of lncRNAs expressed in pancreatic tissues, as well as to identify expression signatures correlated to tissue histology. Strand-specific reverse transcription followed by PCR and qRT-PCR were employed to determine strandedness of lncRNAs and to validate microarray results, respectively.</p> <p>Results</p> <p>We show that subsets of intronic/intergenic lncRNAs are expressed across tumor and non-tumor pancreatic tissue samples. Enrichment of promoter-associated chromatin marks and over-representation of conserved DNA elements and stable secondary structure predictions suggest that these transcripts are generated from independent transcriptional units and that at least a fraction is under evolutionary selection, and thus potentially functional.</p> <p>Statistically significant expression signatures comprising protein-coding mRNAs and lncRNAs that correlate to PDAC or to pancreatic cancer metastasis were identified. Interestingly, <it>loci </it>harboring intronic lncRNAs differentially expressed in PDAC metastases were enriched in genes associated to the MAPK pathway. Orientation-specific RT-PCR documented that intronic transcripts are expressed in sense, antisense or both orientations relative to protein-coding mRNAs. Differential expression of a subset of intronic lncRNAs (<it>PPP3CB</it>, <it>MAP3K14 </it>and <it>DAPK1 loci</it>) in metastatic samples was confirmed by Real-Time PCR.</p> <p>Conclusion</p> <p>Our findings reveal sets of intronic lncRNAs expressed in pancreatic tissues whose abundance is correlated to PDAC or metastasis, thus pointing to the potential relevance of this class of transcripts in biological processes related to malignant transformation and metastasis in pancreatic cancer.</p>http://www.molecular-cancer.com/content/10/1/141pancreatic cancermolecular markersnoncoding RNAsintronic transcriptionmetastasis<it>MAPK </it>pathwaycDNA microarrays
spellingShingle Tahira Ana C
Kubrusly Márcia S
Faria Michele F
Dazzani Bianca
Fonseca Rogério S
Maracaja-Coutinho Vinicius
Verjovski-Almeida Sergio
Machado Marcel CC
Reis Eduardo M
Long noncoding intronic RNAs are differentially expressed in primary and metastatic pancreatic cancer
Molecular Cancer
pancreatic cancer
molecular markers
noncoding RNAs
intronic transcription
metastasis
<it>MAPK </it>
pathway
cDNA microarrays
title Long noncoding intronic RNAs are differentially expressed in primary and metastatic pancreatic cancer
title_full Long noncoding intronic RNAs are differentially expressed in primary and metastatic pancreatic cancer
title_fullStr Long noncoding intronic RNAs are differentially expressed in primary and metastatic pancreatic cancer
title_full_unstemmed Long noncoding intronic RNAs are differentially expressed in primary and metastatic pancreatic cancer
title_short Long noncoding intronic RNAs are differentially expressed in primary and metastatic pancreatic cancer
title_sort long noncoding intronic rnas are differentially expressed in primary and metastatic pancreatic cancer
topic pancreatic cancer
molecular markers
noncoding RNAs
intronic transcription
metastasis
<it>MAPK </it>
pathway
cDNA microarrays
url http://www.molecular-cancer.com/content/10/1/141
work_keys_str_mv AT tahiraanac longnoncodingintronicrnasaredifferentiallyexpressedinprimaryandmetastaticpancreaticcancer
AT kubruslymarcias longnoncodingintronicrnasaredifferentiallyexpressedinprimaryandmetastaticpancreaticcancer
AT fariamichelef longnoncodingintronicrnasaredifferentiallyexpressedinprimaryandmetastaticpancreaticcancer
AT dazzanibianca longnoncodingintronicrnasaredifferentiallyexpressedinprimaryandmetastaticpancreaticcancer
AT fonsecarogerios longnoncodingintronicrnasaredifferentiallyexpressedinprimaryandmetastaticpancreaticcancer
AT maracajacoutinhovinicius longnoncodingintronicrnasaredifferentiallyexpressedinprimaryandmetastaticpancreaticcancer
AT verjovskialmeidasergio longnoncodingintronicrnasaredifferentiallyexpressedinprimaryandmetastaticpancreaticcancer
AT machadomarcelcc longnoncodingintronicrnasaredifferentiallyexpressedinprimaryandmetastaticpancreaticcancer
AT reiseduardom longnoncodingintronicrnasaredifferentiallyexpressedinprimaryandmetastaticpancreaticcancer